Articles tagged with Fatty Liver Disease
Researchers found significant ethnic differences in NAFLD prevalence, with striking variations among Hispanics, whites, and blacks. Hepatic steatosis was more common in Hispanics and less common in blacks, highlighting fundamental differences in lipid homeostasis.
The Mayo Clinic discovery sheds light on the cellular mechanisms behind Non-Alcoholic Fatty Liver Disease (NAFLD), a growing global problem related to affluence and diet. Early signs include accumulation of fat in the liver, inflammation, and scarring, which can lead to impaired function.
Researchers have identified a link between obesity, digestive system malfunctions, and excessive alcohol production in the liver. Feeding obese mice antibiotics significantly reduced alcohol production, suggesting a potential treatment strategy using oral antibiotics or yogurt to constrain intestinal bacterial overgrowth.
A new study reveals that free radicals, generated by the macrophage enzyme NADPH oxidase, are essential for the development of alcoholic liver disease. The researchers found that mice lacking this enzyme were resistant to liver injury and had lower levels of covalent adducts in their bile.
A study published in Nature Medicine found that metformin may help treat fatty liver disease in patients with obesity-related insulin resistance. The drug completely cured fatty liver in mice and showed promise in reducing liver inflammation and improving insulin sensitivity.
Scientists have identified TNF-alpha as a major contributor to early liver injury from long-term alcohol consumption, paving the way for new treatments. The study used gene knockout technology and found that mice lacking TNF receptors fared better on measures of liver injury after alcohol exposure.
A study found that tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in early liver damage caused by alcohol consumption. The researchers used gene knockout technology to show that TNF-alpha mediates the development of liver injury, leading to potential new drug therapies for conditions affecting millions of Americans.
A recent study published in the New England Journal of Medicine found that genetic testing and dietary modification can save the lives of children born with a defect in fatty acid breakdown. The research team identified 24 infants with liver, heart, or muscular abnormalities and found that dietary treatment was crucial for survival.
Researchers recommend genetic screening for pregnant women with liver illness and their families to prevent life-threatening conditions. The E474Q mutation is identified in 19 children out of 24 families studied, leading to AFLP or other liver disorders in mothers.